Organigram Global (OGI) Cash & Equivalents (2023 - 2025)

Organigram Global (OGI) has disclosed Cash & Equivalents for 3 consecutive years, with $60.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 37.51% to $60.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $60.7 million, a 37.51% decrease, with the full-year FY2025 number at $59.8 million, down 38.65% from a year prior.
  • Cash & Equivalents was $60.7 million for Q3 2025 at Organigram Global, down from $97.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $97.2 million in Q3 2024 to a low of $38.6 million in Q3 2023.
  • A 3-year average of $65.5 million and a median of $60.7 million in 2025 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 151.78% in 2024, then crashed 37.51% in 2025.
  • Organigram Global's Cash & Equivalents stood at $38.6 million in 2023, then soared by 151.78% to $97.2 million in 2024, then crashed by 37.51% to $60.7 million in 2025.
  • Per Business Quant, the three most recent readings for OGI's Cash & Equivalents are $60.7 million (Q3 2025), $97.2 million (Q3 2024), and $38.6 million (Q3 2023).